Intuitive Surgical, Inc. (NASDAQ:ISRG) Insider Jamie Samath Sells 269 Shares

Intuitive Surgical, Inc. (NASDAQ:ISRG) insider Jamie Samath sold 269 shares of the stock in a transaction dated Monday, November 11th. The shares were sold at an average price of $539.89, for a total transaction of $145,230.41. Following the completion of the sale, the insider now owns 8,757 shares of the company’s stock, valued at approximately $4,727,816.73. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website.

Jamie Samath also recently made the following trade(s):

• On Friday, November 8th, Jamie Samath sold 22,903 shares of Intuitive Surgical stock. The stock was sold at an average price of $525.00, for a total transaction of $12,024,075.00.

Intuitive Surgical Price Performance

ISRG stock traded up $1.32 during midday trading on Tuesday, reaching $537.07. 1,455,926 shares of the company’s stock traded hands, compared to its average volume of 1,459,553. The business has a 50-day moving average price of $494.78 and a two-hundred day moving average price of $453.94. The company has a market capitalization of $191.29 billion, a P/E ratio of 86.13, a PEG ratio of 5.27 and a beta of 1.39. Intuitive Surgical, Inc. has a fifty-two week low of $281.12 and a fifty-two week high of $542.59.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, beating analysts’ consensus estimates of $1.24 by $0.32. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. The company had revenue of $2.04 billion for the quarter, compared to the consensus estimate of $2.01 billion. As a group, research analysts forecast that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Intuitive Surgical

A number of institutional investors have recently modified their holdings of the business. Ridgewood Investments LLC purchased a new stake in shares of Intuitive Surgical in the second quarter worth approximately $26,000. Godsey & Gibb Inc. lifted its stake in shares of Intuitive Surgical by 140.0% in the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after acquiring an additional 35 shares during the last quarter. Creekmur Asset Management LLC lifted its stake in shares of Intuitive Surgical by 200.0% in the 1st quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock valued at $25,000 after purchasing an additional 42 shares during the period. LGT Financial Advisors LLC increased its holdings in shares of Intuitive Surgical by 415.4% in the 2nd quarter. LGT Financial Advisors LLC now owns 67 shares of the medical equipment provider’s stock worth $30,000 after purchasing an additional 54 shares in the last quarter. Finally, MidAtlantic Capital Management Inc. purchased a new position in Intuitive Surgical during the third quarter valued at $33,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Analyst Upgrades and Downgrades

ISRG has been the topic of a number of analyst reports. Morgan Stanley boosted their price objective on shares of Intuitive Surgical from $375.00 to $460.00 and gave the company an “equal weight” rating in a research report on Monday, July 15th. Piper Sandler reiterated an “overweight” rating and issued a $538.00 target price (up previously from $495.00) on shares of Intuitive Surgical in a research note on Friday, October 18th. Robert W. Baird upped their target price on shares of Intuitive Surgical from $503.00 to $565.00 and gave the stock an “outperform” rating in a research note on Thursday, October 17th. Mizuho increased their price objective on shares of Intuitive Surgical from $440.00 to $500.00 in a research report on Thursday, October 17th. Finally, Citigroup upped their target price on shares of Intuitive Surgical from $512.00 to $560.00 and gave the company a “buy” rating in a report on Thursday, August 22nd. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and fourteen have issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $513.74.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.